Voluntary announcement - on-market share repurchase
Filed with HKEX · Stock code 9637 · · 2 pages · English
Summary by 6ix AI
Alebund Pharmaceuticals (Jiangsu) Limited has announced a voluntary share repurchase plan for its H shares on the Hong Kong Stock Exchange. The board intends to repurchase shares for a total amount up to a specified limit, using its own financial resources. The share repurchase is aimed at safeguarding shareholder value and demonstrating confidence in the company's business outlook. As of the announcement date, no shares have yet been repurchased under this mandate.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Alebund Pharmaceuticals (Jiangsu) Limited on 6ix
Earlier from Alebund Pharmaceuticals (Jiangsu)
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
- 2026 Interim report
- Alebund's AP301 NDA Accepted for Review by China's NMPA
- Announcement of final offer price and allotment results
- List of directors and their roles and functions
Later from Alebund Pharmaceuticals (Jiangsu)
- Next Day Disclosure Return
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
Follow Alebund Pharmaceuticals (Jiangsu) into a list and get an email when it puts out news.
Follow Alebund Pharmaceuticals (Jiangsu)